Autism Treatments – Clinical Research Trials

Autism Treatments – Clinical Research Trials

clinical trials autism research participants

Ongoing UK Clinical Trials for Autism – research studies recruiting participants

The following is a list of research trials currently taking place in the UK and actively recruiting study participants. The studies have been designed to investigate the potential of various medications and interventions to help reduce core autism symptoms, and/or difficulties and symptoms frequently experienced by individuals affected by autism such as anxiety, irritability, impulsive, aggressive and self-harming and other challenging behaviours.

Please note that the studies are not run by Thinking Autism. We can not reply to questions about the studies, the treatments themselves, or your or your child’s eligibility to take part in the trials. If you have any questions about the trials or would like your child/ren or yourself to take part in one of the studies please contact the institutions that are running the trials via the links provided.

Please note: the list is not comprehensive. If your organisation is running a trial and recruiting participants who live in the UK please contact us to have it added to the list. In order to qualify for a listing the aims and objectives of the study need to fall under one or both of the following categories: 1. reducing core symptoms of autism 2. addressing underlying or comorbid biomedical disorders that contribute to symptoms and difficulties experienced by individuals with autism.

The list will be updated on an ongoing basis. Please make sure to come back and refresh the page from time to time, or subscribe to our mailing list to be informed of future additions.

New Study To Evaluate Psilocybin’s Therapeutic Potential On Autistic Adults (LONDON)

A new study, led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London will explore the potential therapeutic effects of psilocybin on autistic adults.

The study will explore how psilocybin affects specific brain pathways in autistic adults, and is the first ever mechanistic study of psilocybin in autistic adults.

It will investigate whether there is a difference in the function of serotonin brain networks in autistic and non-autistic adults. The researchers will use a range of imaging techniques and behavioural tasks to examine how the serotonin system is modulated by COMP360 psilocybin. It is an investigator-initiated exploratory study that will take place at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London. The study is co-sponsored by King’s IoPPN and South London and Maudsley NHS Foundation Trust. It will enrol 70 adult participants, including 40 autistic people and 30 non-autistic people.

 

https://www.kcl.ac.uk/news/new-study-to-evaluate-magic-mushrooms-therapeutic-potential-on-autistic-adults

Thinking Autism blog – science news & updates

Aggression In Autism – One Simple Cause

Aggression In Autism – One Simple Cause

In addition to the core symptoms of autism, which include social communication difficulties, restricted interests, and sensory processing difficulties, both children and adults with autism often present with many other ‘autism-related’ symptoms and behaviours....

read more
Depression in Autism – More Than Meets The Eye?

Depression in Autism – More Than Meets The Eye?

High rates of depression and suicide in autism   Depression is a common and serious problem in autism, and one of the main contributors to poor quality of life. Both children and adults with autism experience high rates of depression and other mood disorders. One...

read more
Addressing Poor Health & High Death Rates in Autism

Addressing Poor Health & High Death Rates in Autism

“We must first recognise ASD as a whole body disorder” Autism, or Autism Spectrum Disorder ASD, is traditionally seen as the result of behavioural and neuropsychiatric dysfunction. However there is a strong evidence that various physical, or biomedical, problems can...

read more
Synchrony 2019 – Translational Research in Autism symposia

Synchrony 2019 – Translational Research in Autism symposia

The first Brain Foundation annual symposia, Pleasanton, California 8-10 of Nov 2019, aimed to connect researchers with clinicians, donors & stake holders to help translate research efforts into evidence-based treatments for autism and its co-morbidities. It highlighted the need for multidisciplinary collaboration, detailed diagnostics and personalised treatment…

read more